Stage III Breast Cancer: Gail's Patient Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage III
- Biomarkers
- Luminal A
- Sex
- Female
- Treatment
- surgery, radiation, chemotherapy and hormone therapy
- Outcome
- Care Ongoing
Treatment course, step by step
- Planned treatment after August 2024 diagnosis: lumpectomy, radiation therapy, chemotherapy with at least 6 sessions expected, and hormone therapy.
- Treatment had not yet started at the time described.
What happened, in summary
Gail, 65, is a mother of 2 from the United Kingdom who works in administration. In August 2024, she was diagnosed with Stage III luminal A breast cancer after feeling a lump in her breast that did not go away after a few weeks. She was surprised by the diagnosis because she had first been told the lump was almost certainly a cyst. Gail had also lost a niece to breast cancer, so the news carried extra emotional weight. At the point described, she had not yet started treatment, but she and her doctor had agreed on a plan. The plan included lumpectomy, radiation therapy, chemotherapy, and hormone therapy. She was told she would need at least 6 chemotherapy sessions. Financial support from the NHS helped reduce some practical pressure. Gail changed her diet dramatically after diagnosis but continued working with accommodations from her employer because work helped take her mind off cancer. She looked forward to booking a holiday after treatment. Her biggest fear was dying and not being with her family, and she tried to manage that fear by learning more about the disease and its treatments. With a plan in place, she felt optimistic and ready to move forward.
Where this story comes from
This is a lay summary of an account first published by Our Cancer Stories. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer